Europe investigates adverse effects of injections to lose weight

Europe investigates adverse effects of injections to lose weight

The European Medicines Agency (EMA) launched a review of the safety of the active ingredients in weight-loss injections: semaglutide (Ozempic, Rybelsus) and liraglutide (Saxenda, Victoza), after receiving reports of suicidal ideation and self-harm in patients using this medicine.

The EMA estimates that each year some 20 million patients resort to one of these two active ingredients.

Weight-loss injections under the spotlight

GLP-1 analogues are active substances (mostly injectable) indicated for the treatment of type 2 diabetes and people with obesity who do not have diabetes, details the Mayo Clinic. Two of these principles: Liraglutide (Saxenda) and semaglutide (Ozempic) have become popular because they are also used for weight loss, although only Saxenda is recommended for this purpose.

According to the EMA, it has been decided to initiate a review on the safety of all medicines containing GLP-1 analogues after receiving various notifications from the Icelandic Medicines Agency of patients who, using medicines containing one of these active substances, had Suicidal ideation or self-harm.

So far, 150 possible cases have been reported. The EMA investigation will determine whether or not these events are related to the use of the injected drugs to lose weight. At the moment, neither suicidal ideation nor self-harm appear as possible adverse effects of these drugs.

There are other drugs involved

In addition to the Saxenda or Ozempic weight loss injections, there are other medicines that also contain semaglutin, liraglutide or other GLP-1 analogue active substances. The review now carried out by EMA includes all of them:

rybelsus tablets (semaglutide)

Ozempic injection (semaglutide)

victory injection (liraglutide)

Saxenda injection (liraglutide)

lyxumia injection (lixisenatide)

Trulicity injection (dulaglutide)

Byetta injectable (exenatide)

It is estimated that the EMA investigation will end in November 2023. In the event that the agency determines that these active ingredients do indeed induce suicidal ideation and self-harm, new recommendations will be issued for their use.

In case of using injections to lose weight, always ask your doctor about the possible adverse reactions of these treatments.

Kumneger Media
Kumneger Media
Kumneger Media is a News and Entertainment Website & Channel. Kumneger Media in addition to News and Entertainment it is the hub of Politics, Movies, Drama, Music, Comedy, Documentary and More!